Global biotechnology instruments market to reach USD 94.8 billion by 2027. Global biotechnology instruments market is valued approximately at USD 41.14 billion in 2020 and is anticipated to grow with a healthy growth rate of about 12.66% over the forecast period 2021-2027. Biotechnology instruments refers to a range of instruments and equipment that are used in the biotechnology sector for research and development activities. The global biotechnology instruments market is being driven by rising demand for Point-of-care (POC) devices and tests and increasing prevalence of target diseases with rising geriatric population. Furthermore, technological advancements and developments will provide new opportunities for the global biotechnology instruments industry. Market players across the globe are strengthening their presence in the market through different strategic initiatives. For instance, in 2021, Beckman Coulter introduced a tabletop hematology analyzer, DXH560 AL. The tabletop hematology analyzer is intended to reduce the resource and time restriction which is faced by small- and mid- sized laboratories. The newly developed tabletop hematology analyzer offers results within one minute or less. Also, in 2021, Lumenis unveiled MOSES 2.0, which is a next-generation holmium laser technology developed to improve the efficiency of urinary stones as well as enlarged prostate procedures by the optimization of laser energy transmission. Such strategic initiatives taken by the market players are expected to proliferate the adoption of biotechnology instruments which is expected to boost the market growth. However, higher cost of devices may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global biotechnology instruments market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America accounts for the largest share in terms of market revenue in the global biotechnology instruments market over the forecast period 2021-2027. Factors such as high affordability and demand of biotechnology instrumentation, inclination towards manual automation in the pharmaceuticals, biotechnology, and related industries, government funding for research and development, etc. contribute towards the largest market share of the region in the forecast years.

Major market player included in this report are:
Abbott
Agilent Technologies
Alcon, Inc.
AngioDynamics
Becton, Dickinson and Company
BioMerieux SA
Bio-Rad Laboratories
BioTek Instruments, Inc.
Candela Medical
Cynosure, LLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Lab Automation Instruments
Life Science Consumables
IVD Instruments
Medical Lasers
By End-Use:
Government & Academic Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Healthcare Facilities
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Biotechnology Instruments Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors